MC8-89751-70809
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 531 / WI
- Registered
- 2022-06-22
- Relationship
- Child or adolescent in my care
- Guardian
- EJP-79373-15601
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-16
Dose 1 — Pfizer-BioNTech
-
2022-06-22
Registered in v-safe
- 2022-06-22
- 2022-06-23
- 2022-06-30
-
2022-07-07
Dose 2 — Pfizer-BioNTech
- 2022-07-14
- 2022-07-21
- 2022-07-28
- 2022-08-04
- 2022-08-11
-
2022-08-18
Survey response — day 42, dose 2, dependentMedDRA: Respiratory tract congestion, Rhinorrhoea, Urinary tract discomfort — Feeling: GoodFree text: Runny nose, congestion, minor irritation on penis when peeing.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-06
- 2023-01-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-16 | Pfizer-BioNTech | No |
| 2 | 2022-07-07 | Pfizer-BioNTech | No |
Free text
Release 12 — day 42, dose 2, dependent
Symptoms: Runny nose, congestion, minor irritation on penis when peeing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Urinary tract discomfort | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release